IPO Status: Closed [16th Dec 2021 to 20th Dec 2021]
Supriya Lifescience IPO of Rs 700 Cr is opening soon to list on the BSE and NSE. The IPO opens for subscription from 16 to 20 Dec, 2021. The face value per share is Rs. 2 and the IPO price band is Rs. 265-274 and the lot size is 54 shares. Stay updated with us to know more about the Supriya Lifescience IPO issue size, minimum order amount, business overview, company financials, live subscription, grey market premium (GMP), allotment status, and more.
|IPO Issue Opening Date:||16th Dec 2021|
|IPO Issue Closing Date:||20th Dec 2021|
|IPO Issue Price:||₹265-274|
|IPO Listing At:||BSE, NSE|
|IPO Issue Type:||Book Built Issue IPO|
|IPO Issue Size:||₹700 Cr|
|Offer for Sale:||₹500 Cr|
|Fresh Issue:||₹200 Cr|
|Face Value:||₹2 Per Equity Share|
|Promoter Holding Pre IPO:||99.26|
|Promoter Holding Post IPO:||67.59|
Save 60% to 90% Brokerage
Start your investment journey with India's number one discount broker - Zerodha. Free delivery trade and free mutual funds Investment. Flat Rs 20 for Intraday,F&O, Currency and Commodity Trade.
Open Account Now
In this section we have covered all important dates related to Supriya Lifescience IPO. Dates are updated as they are announced. The most noted dates are IPO start date and IPO end date, which one should use to participate in IPO.
|IPO Issue Open||16th Dec 2021|
|IPO Issue Close||20th Dec 2021|
|Basis of Allotment Date*||23rd Dec 2021|
|Refunds Initiation*||24th Dec 2021|
|Credit of Shares to Demat*||27th Dec 2021|
|IPO Listing Date*||28th Dec 2021|
* - Tentative Dates
|Market Lot:||54 Shares|
|1 Lot Amount:||₹14796|
|Max Retail Lots:||702 shares (13 lots)|
|Min HNI Lots:||756 shares (14 lots)|
Supriya Lifescience Limited is one of the biggest manufacturers and suppliers of active pharmaceutical ingredients (API). The company has a manufacturing facility located in Parshuram Lote, Maharashtra. The manufacturing unit has approval from major export countries for API supplies which include USFDA, EDQM, and EUGMP from AIFA – Italy, TGA-Australia, BfArM-Germany, KFDA-Korea, PMDA-Japan, SFDA- China, COFEPRIS – Mexico, etc. The company also has a DSIR approved R&D facility in Parshuram Lote, MH with a team of 16 scientists. Supriya Lifescience has a presence in domestic as well as international markets. At present, the company is exporting products in 78 countries.
|Incorporation||Sector||IPO Issue Size||Website|
The IPO aims to raise funds for the following purposes;
The table below is live update of IPO bidding details from NSE and BSE.
|# of Shares Offered||7,924,527 (54.55%)||3,962,263 (27.27%)||2,641,509 (18.18%)||14,528,299||1||16th Dec 2021 17:02||0.00x||0.66x||11.84x||2.33x||2||17th Dec 2021 17:02||0.53x||2.90x||25.38x||5.69x||3||18th Dec 2021 09:18||0.53x||2.90x||25.38x||5.69x||4||20th Dec 2021 19:54||31.83x||161.22x||56.01x||71.51x|
Past performance and financial results of Supriya Lifescience.
|Supriya Lifescience Financials (₹ in Cr)||31-Sep-2021||31-Mar-2021||31-Mar-2020||31-Mar-2019|
Supriya Lifescience IPO DRHP >>Document
Supriya Lifescience IPO RHP >>Document
Supriya Lifescience IPO Allotment Status >>Link
Last Updated on 2022-01-05T10:39:57+00:00
Free Delivery for Lifetime
Flat ₹10 Per Trade in F&O
Rs 0 Demat AMC
FREE Account Opening (
Trade at Flat ₹20 per Trade Pay-as-you-go Demat AMC
Flat ₹20 Per Trade
Free Trading Tips & Software